Remedia Pharmaceuticals Private Limited

Remedia Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U24110MH1988PTC047148 Incorporated 25 April 1988 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2026
₹1.05 Cr
▲ 41% YoY
Net loss · FY 2026
₹8.81 Lakh
Net margin -8.4%
EBITDA · FY 2026
-₹8.78 Lakh
EBITDA margin -8.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹3.44 Lakh
Satisfied ₹3.66 Lakh
Company age
38 yrs
Est. 1988
Employees · EPFO
1
Provident fund records

About Remedia Pharmaceuticals Private Limited

Data last updated:

Remedia Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 1988 and has been in existence for over 38 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH1988PTC047148. Its GSTIN is 27AAACR2157A2ZU (Maharashtra). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sunil Govind Shetty and Deepa Sunil Shetty.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Gala 1 – 5 Patel Industrial Estate No 3 Navghar Vasai East, Thane, Maharashtra, India – 401210.

As per the financials filed for FY 2026, the company reported a revenue of ₹1.05 Cr, a growth of 41% compared to the previous year. For the same year it recorded a net loss of ₹8.81 Lakh (net margin -8.4%) and EBITDA of -₹8.78 Lakh (EBITDA margin -8.3%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 38% over five years.

The company has about 1 employee on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹3.44 Lakh and satisfied charges of ₹3.66 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.

Remedia Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0067558). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24110MH1988PTC047148
Registration Number 047148
Incorporation Date 25 April 1988
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-17-0067558
Key People
Sunil Govind Shetty Director Deepa Sunil Shetty Director

Recognitions & Rankings of Remedia Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-17-0067558

Contact details

Remedia Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Gala 1 – 5 Patel Industrial Estate No 3 Navghar Vasai East, Thane, Maharashtra, India – 401210
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Remedia Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Remedia Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Remedia Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Remedia Pharmaceuticals Private Limited, buy the company report.

Financials of Remedia Pharmaceuticals Private Limited

FY 2026 filings available

Remedia Pharmaceuticals Private Limited reported revenue of ₹1.05 Cr (up 41% YoY) for FY 2026.

Revenue · FY 2026
₹1.05 Cr ▲ 41%
Net loss · FY 2026
₹8.81 Lakh margin -8.4%
EBITDA · FY 2026
-₹8.78 Lakh margin -8.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 41%
3 years · compounded
▲ 37%
5 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▲ 8%

Revenue has grown at a compounded annual rate (CAGR) of 38% over five years, including 41% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1.05 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹8.78 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹8.81 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-8.3%
Net Profit Margin-8.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Remedia Pharmaceuticals Private Limited, buy the company report.

Board of directors of Remedia Pharmaceuticals Private Limited

Remedia Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sunil Govind ShettyDirector15 Dec 198837 Years 10 MonthsCurrent
Deepa Sunil Shetty
Also directs: Panorama Plastics Private Limited, Super Tin Containers Private Limited
Director10 Oct 20188 Years 1 MonthsCurrent
View all directors

Auditor

Remedia Pharmaceuticals Private Limited is audited by S B J S & Associates for the financial year 2026.

Auditor firmFinancial yearFirm registration number
S B J S & AssociatesFY 2026157700W

Shareholding

The shareholding of Remedia Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Remedia Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹3.44 Lakh
Satisfied charges
₹3.66 Lakh
Breakdown by lending institutions
State Bank of India₹0.03 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Sep 2020100383444State Bank of India₹3.44 LakhOpen
06 Aug 200290223374New India Co-Op. Bank Ltd.₹3.66 LakhSatisfied

To see the full charge records of Remedia Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Remedia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Remedia Pharmaceuticals Private Limited has a workforce of 1 employees on its EPFO records as of Dec 2024, across 1 active EPFO establishment.

Employee count
1
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2024-251
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Remedia Pharmaceuticals Private Limited, buy the company report.

GST

Remedia Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAACR2157A2ZUMaharashtraActive21 Jul 2017

To see the full GST registrations and return filing status of Remedia Pharmaceuticals Private Limited, buy the company report.

Recent activity

Remedia Pharmaceuticals Private Limited has 3 board changes on record since 1988: 2 appointments and 1 cessation. The latest: Kaup Govind Shetty ceased to be Director on 17 Mar 2019.

Filing
Remedia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai.
AGM
Remedia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 3.44 Lakh with Charge ID 100383444 was registered on 28 Sep 2020.
Charges
A charge registered on 06 Aug 2002 via Charge ID 90223374 with New India Co-Op. Bank Ltd. was fully satisfied on 25 Aug 2020.
Ceased
Kaup Govind Shetty ceased to be Director.
Appointed
Deepa Sunil Shetty was appointed as Director.
Charges
A charge with New India Co-Op. Bank Ltd. amounted to Rs. 3.66 Lakh with Charge ID 90223374 was registered on 06 Aug 2002.
Appointed
Sunil Govind Shetty was appointed as Director.
Incorporation
25 Apr 1988
Remedia Pharmaceuticals Private Limited was registered on 25 Apr 1988 with Roc Mumbai & aged 38 years 6 months as per MCA records.

Frequently asked questions

Remedia Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 1988 (38+ years old) and is registered under CIN U24110MH1988PTC047148.

Remedia Pharmaceuticals has 2 current directors:

The latest financial statements of Remedia Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Remedia Pharmaceuticals is 27AAACR2157A2ZU, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Remedia Pharmaceuticals is U24110MH1988PTC047148. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Remedia Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.

Remedia Pharmaceuticals was incorporated on 25 April 1988, making it 38+ years old. It is registered with the Registrar of Companies, Mumbai.

Kaup Govind Shetty ceased to be Director on 17 Mar 2019. Deepa Sunil Shetty was appointed as Director on 10 Oct 2018. Sunil Govind Shetty was appointed as Director on 15 Dec 1988.

Yes, Remedia Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0067558).

The registered office of Remedia Pharmaceuticals is at Gala 1 – 5 Patel Industrial Estate No 3 Navghar Vasai East, Thane, Maharashtra, India – 401210.